Correlated Drug Terms (1)

---

	Name (Synonyms)	Correlation
drug1303	L-ascorbic acid Wiki	0.71

Correlated MeSH Terms (3)

---

	Name (Synonyms)	Correlation
D000860	Hypoxia NIH	0.23
D045169	Severe Acute Respiratory Syndrome NIH	0.05
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (1)

---

	Name (Synonyms)	Correlation
HP:0012418	Hypoxemia HPO	0.23

Primary Outcomes

Description: Identify risk factors for intra-hospital mortality in patients admitted to the COVID + hospital wards of San Gerardo hospital.

Measure: Identify risk factors for intra-hospital mortality.

Time: Until patient discharge from the hospital (approximately 1 year)

---

Description: Identify the risk factors to build a prognostic score through which it is possible to define a stratification that immediately guides the therapeutic choices.

Measure: Identify risk factors to build a prognostic score.

Time: Until patient discharge from the hospital (approximately 1 year)

---

Description: Identify the risk factors to build a prognostic score through which it is possible to define a stratification that immediately directs towards the right intensity of care.

Measure: Identify risk factors to build a prognostic score.

Time: Until patient discharge from the hospital (approximately 1 year)

---

Secondary Outcomes

Description: Description of the predictive factors for the hospitalization duration.

Measure: Predictive factors for the hospitalization duration.

Time: Until patient discharge from the hospital (approximately 1 year)

---

Description: Description of the predictive factors for the clinical status of patients based on "Ordinal Scale for Clinical Improvement" defined by OMS (

Measure: Predictive factors for clinical status patients based on "Ordinal Scale for Clinical Improvement"

Time: Until patient discharge from the hospital (approximately 1 year)

---

Description: Description of efficacy of the anti-viral therapies used today without particular restrictions, but on which solid clinical functioning tests are lacking.

Measure: Describe the anti-viral therapies used commonly in this emergency in terms of efficacy

Time: Until patient discharge from the hospital (approximately 1 year).

---

Description: Description of safety of the anti-viral therapies used today without particular restrictions, but on which solid clinical functioning tests are lacking.

Measure: Describe the anti-viral therapies used commonly used in this emergency in terms of safety

Time: Until patient discharge from the hospital (approximately 1 year).

---

Description: Description of the disease clinical course in patients 12 months after discharge (mortality, neurological, respiratory and cardiac outcomes).

Measure: Monitor the clinical course of the disease in discharged patients.

Time: 12 month after discharge

---